Posted by Anthony Bellafiore on Jan 31st, 2025
Athira Pharma, Inc. (NASDAQ:ATHA – Get Free Report) was the target of a large decrease in short interest in the month of January. As of January 15th, there was short interest totalling 1,170,000 shares, a decrease of 17.6% from...
More of this article »